Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

570 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.
Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, Wiedemann P, Simader C, Gekkieva M, Weichselberger A; EXCITE Study Group. Schmidt-Erfurth U, et al. Among authors: wiedemann p. Ophthalmology. 2011 May;118(5):831-9. doi: 10.1016/j.ophtha.2010.09.004. Epub 2010 Dec 13. Ophthalmology. 2011. PMID: 21146229 Clinical Trial.
The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
Lang GE, Liakopoulos S, Vögeler J, Weiß C, Spital G, Gamulescu MA, Lohmann C, Wiedemann P. Lang GE, et al. Among authors: wiedemann p. Acta Ophthalmol. 2018 May;96(3):e377-e385. doi: 10.1111/aos.13574. Epub 2017 Nov 1. Acta Ophthalmol. 2018. PMID: 29090846 Free PMC article. Clinical Trial.
Relevance of Retinal Thickness Changes in the OCT Inner and Outer Rings to Predict Progression to Clinical Macular Edema: An Attempt of Composite Grading of Macular Edema.
Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Erginay A, Verbraak FD, Lund-Andersen H, Martinez JP, Jürgens I, Smets E, Coriat C, Wiedemann P, Ágoas V, Querques G, Holz FG, Nunes S, Alves D, Neves C, Santos T, Ribeiro L, Bandello F, Tejerina AN, Cunha-Vaz J; EVICR.net. Vujosevic S, et al. Among authors: wiedemann p. Ophthalmic Res. 2015;55(1):19-25. doi: 10.1159/000441110. Epub 2015 Nov 6. Ophthalmic Res. 2015. PMID: 26555067
Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.
Ribeiro L, Bandello F, Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Massin P, Verbraak FD, Lund-Andersen H, Martinez JP, Jürgens I, Smets E, Coriat C, Wiedemann P, Ágoas V, Querques G, Holz FG, Nunes S, Neves C, Cunha-Vaz J; Evicr Net Study Group. Ribeiro L, et al. Among authors: wiedemann p. Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5698-705. doi: 10.1167/iovs.15-16708. Invest Ophthalmol Vis Sci. 2015. PMID: 26322834 Clinical Trial.
570 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page